Matthew Goff Investment Advisor’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$984K Sell
15,374
-325
-2% -$21.4K 0.17% 59
2026
Q1
$1.12M Sell
15,699
-452
-3% -$35.6K 0.19% 67
2025
Q4
$1.32M Sell
16,151
-483
-3% -$37.6K 0.23% 49
2025
Q3
$1.25M Sell
16,634
-183
-1% -$13.6K 0.21% 54
2025
Q2
$1.25M Sell
16,817
-55
-0.3% -$3.83K 0.23% 53
2025
Q1
$1.36M Sell
16,872
-179
-1% -$15.4K 0.25% 56
2024
Q4
$1.33M Sell
17,051
-34
-0.2% -$2.89K 0.25% 59
2024
Q3
$1.6M Sell
17,085
-183
-1% -$15.4K 0.31% 54
2024
Q2
$1.35M Sell
17,268
-286
-2% -$23.3K 0.27% 56
2024
Q1
$1.6M Sell
17,554
-120
-0.7% -$9.98K 0.32% 51
2023
Q4
$1.37M Sell
17,674
-537
-3% -$37.6K 0.3% 52
2023
Q3
$1.24M Sell
18,211
-154
-0.8% -$11.2K 0.3% 51
2023
Q2
$1.49M Buy
18,365
+242
+1% +$19.3K 0.35% 51
2023
Q1
$1.49M Buy
+18,123
New +$1.29M 0.37% 51

Other funds holding GEHC

Matthew Goff Investment Advisor's GEHC Position: Q2 2026 in Review

Matthew Goff Investment Advisor reduced its GE HealthCare (GEHC) stake by 2.1% in Q2 2026, selling an estimated $21.4K and leaving 15,374 shares worth $984K. The position accounts for 0.17% of the portfolio, ranked #59.

Matthew Goff Investment Advisor first reported a position in GEHC in Q1 2023 and has held it in 14 quarters since. The position peaked at $1.6M in Q3 2024. 178 funds tracked by Wall St. Rank hold GEHC as of Q2 2026.

  • Matthew Goff Investment Advisor held 15,374 shares of GE HealthCare worth $984K as of Q2 2026.
  • Matthew Goff Investment Advisor sold 325 GE HealthCare shares in Q2 2026, an estimated $21.4K.
  • GE HealthCare made up 0.17% of Matthew Goff Investment Advisor's portfolio in Q2 2026, its #59 holding.
  • Matthew Goff Investment Advisor first reported a position in GE HealthCare in Q1 2023 and has held it in 14 quarters since.
  • Matthew Goff Investment Advisor's GE HealthCare position peaked at $1.6M in Q3 2024.
  • 178 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2026.

Based on Matthew Goff Investment Advisor's 13F filing for Q2 2026, filed 8 Jul 2026.